Navigation Links
Poor sleep quality in first, third trimesters linked to preterm births
Date:10/31/2011

DARIEN, IL Poor sleep quality in both early and late pregnancy has been linked to an increased risk of delivering preterm.

A study published in the Nov. 1 issue of the journal Sleep shows a significant risk for preterm birth in women reporting sleep disruptions during their first and third trimesters. The connection remained even after medical risk factors and income levels were taken into account.

"This supports the growing evidence that poor sleep is an important risk factor for preterm birth," said Michele Okun, PhD, assistant professor of psychiatry and psychology at the University of Pittsburgh School of Medicine.

"It likely occurs in the presence of other risk factors, but sleep can be measured easily and quickly during prenatal visits. Simply by assessing a woman's sleep quality, we may be able to identify a risk early in the pregnancy, when there is time to intervene. The data suggest that beneficial outcomes may be possible through modifications in behavior," Okun said.

Sleep quality in the second trimester did not correlate with increased risk. Okun said sleep often improves modestly during this part of pregnancy, although it is unclear why. One explanation might be hormones or other biological pathways playing a role, but there is no data.

Similarly, Okun and her co-authors suggest a biological cause for the increase in preterm births with disrupted sleep. Poor sleep quality has been shown to initiate inflammation, possibly activating the processes associated with childbirth prematurely. Sleep disruption also might do this in combination with stress, a known activator of inflammation.

Okun said more research is needed, but the early results are encouraging and important.

"The need to reduce adverse pregnancy outcomes remains high," she said. "Despite our advanced society and medical knowledge, we still find a growing number of women having a preterm baby or other adverse outcome."


'/>"/>

Contact: Doug Dusik
ddusik@aasmnet.org
630-737-9700
American Academy of Sleep Medicine
Source:Eurekalert

Related biology news :

1. CHEST 2011: Embargoed studies highlight new sleep disorder research
2. Sleep disruption for breastfed babies is temporary
3. Marker for Alzheimers disease rises during day and falls with sleep
4. First field-based molecular diagnostic test for African sleeping sickness in sight
5. Tired neurons caught nodding off in sleep-deprived rats
6. Parasite strategy offers insight to help tackle sleeping sickness
7. A sleep strategy commonly used by night nurses throws off their circadian clocks
8. Through evolution, cavefish have lost sleep
9. Chimpanzees contagious yawning evidence of empathy, not just sleepiness, study shows
10. Sleeping Trojan horse to aid imaging of diseased cells
11. Brain can learn to overcome sleep apnea: U of T scientist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Jan. 18, 2017 The global biotechnology ... 92.9 billion by 2025, according to a new ... has been adaptive of the function of outsourcing ... 2002. Among the services outsourced, clinical trial management ... Johnson & Johnson was the first pharmaceutical company ...
(Date:1/19/2017)... BD (Becton, Dickinson and Company) (NYSE: BDX ), a ... live webcast of its Annual Meeting of Shareholders on Tuesday, January ... can be accessed from the BD corporate website at http://www.bd.com/investors/ ... ... BD is a global medical technology company that is ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... Clinical Ops Executives 2017 in its continued commitment to the advancement of the ... to discuss current issues related to clinical trial planning and management. , ...
Breaking Biology Technology: